Halie Furrier
Medical · Tucson, AZNPI 1023667623
Payments from drug & device makers
Across 293 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$1K
- UCB, Inc.$786
- Organon$204
- GSK$133
- Pfizer$92
- plus $339 from 11 others
What the payments were for
- Food & beverage$4,866100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 136 | $2,152 |
| Amgen | 80 | $1,160 |
| UCB, Inc. | 36 | $786 |
| Organon | 11 | $204 |
| GSK | 8 | $133 |
| Pfizer | 5 | $92 |
| E.r. Squibb & Sons, L.L.C. | 4 | $80 |
| Johnson & Johnson | 4 | $77 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Radius Health, Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Sanofi | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Novartis | 1 | $20 |
| Celltrion USA Inc. | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $12 |
How this compares
$4,866 in reported general payments places this provider in the 85th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel MiniEtanercept | 19 | $178,285 |
| RinvoqUpadacitinib | 16 | $118,031 |
| SimponiGolimumab | 14 | $85,632 |
| Humira(Cf) PenAdalimumab | 11 | $75,264 |
| Hydroxychloroquine Sulfate | 287 | $13,823 |
| MethotrexateMethotrexate Sodium | 231 | $5,679 |
| Leflunomide | 96 | $4,254 |
| Sulfasalazine DrSulfasalazine | 50 | $2,124 |
| Mycophenolate Mofetil | 11 | $1,968 |
| Sulfasalazine | 48 | $1,519 |
| Prednisone | 260 | $1,508 |
| Azathioprine | 22 | $1,204 |
| Folic Acid | 76 | $845 |
| Pilocarpine Hcl | 14 | $745 |
| Alendronate Sodium | 67 | $453 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $2,152 | $118,03116 claims |
| Johnson & JohnsonSimponi | $77 | $85,63214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 748 medical providers in Arizona.
Other medical in Tucson
- Linda MoorsTucson$122K
- Danielle WergeTucson$27K
- Darek AndersonTucson$10K
- Carlos AguilarTucson$8K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.